Zhejiang Hisoar Pharmaceutical Co. Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zhejiang Hisoar Pharmaceutical Co. Ltd with three other
companies in this sector in China:
Wuhan Jianmin Pharmaceutical Group Co., Ltd.
sales of 2.36 billion Chinese Renmimbi [US$343.23 million]
of which 70%
Heilongjiang ZBD Pharmaceutical Co Ltd
(2.39 billion Chinese Renmimbi [US$347.30 million]
of which 79%
was Pharmaceutical Industry), and
Zhejiang Xianju Pharmaceutical Co Limited
(2.50 billion Chinese Renmimbi [US$363.57 million]
of which 100%
Zhejiang Hisoar Pharmaceutical Co. Ltd reported sales of 2.43 billion Chinese Renmimbi (US$353.43 million)
December of 2016.
decrease of 1.2%
versus 2015, when the company's sales were 2.46 billion Chinese Renmimbi.
Contributing to the drop in overall sales was the 1.6% decline
in Dyes, from 1.22 billion Chinese Renmimbi to 1.20 billion Chinese Renmimbi.
However, these declines were partially offset by the increase in sales of
Pharmatheutical Industry (up 1.8% to 1.25 billion Chinese Renmimbi)